In our study, new patient referrals with an initial value for TSH by IRMA of >0.1 to <50 milli-int. unitsfL showed a strong correlation of the increment in TSH 20 mm after TEl! and the basal value of TSH by IRMA (r = 0.93). This pattern of response was observed even when the basal values for TSH by IRMA were <1 milli-int. unitiL. In these patients, therefore, the basal value for TSH by nui gives as much information as the TEN test concerning thyrotroph function. In hypothalamic and pituitary disease the same correlation may not hold true, but we did not have an opportunity to study such patients.
Concentrations of immunoreactive trypsin (IRT) and pancreatic and salivary amylase activities were measured in 22 patients with primary SjOgren's syndrome (SS) and in 13 patients with secondary SS.Nineteen of the 22 patients with primary SS had above-normal IRT, and six had abovenormal pancreatic isoamylase activity. Six of the 13 patients with secondary SS had above-normal IRT; none had abovenormal isoamylase activities. Serum IRT and pancreatic isoamylase were correlated significantly (r = 0.7; p <0.0001). Above-normal values for IRT and pancreatic isoamylase were more frequent in patients who had SSfor longer than 10 years, but were not related to the presence of salivary gland autoantibodies or to salivary isoamylase activity. We conclude that the concentration and activity of pancreatic enzymes are frequently abnormal in SS; that the abnor- 1, 2) . This leads to a decrease in salivary flow, dryness of the mouth and eyes, and sometimes other exocrine disturbances.
55 is classically subdivided into two groups: primary SS (or sicca syndrome), where exocrine disturbances occur in isolation, and secondary 55, where a well-characterized disorder of connective tissue is also present. This clinical subdivision is supported by clinical, immunological, and immunogenetic differences between the two groups.
Two previous studies suggested that concomitant abnor3Nonstandard abbreviations: SS, SjOgren'ssyndrome; RA, rheumatoid arthritis; SLE, systemic lupus ezythemathsus; IRT, immunoreactive trypsin. We have previously shown that the measurement of pancreatic enzymes trypsin, aniylase, and lipase in serum provides a sensitive index of subclinical abnormalities in pancreatic function, including diabetes mellitus (6), crstic fibrosis (7), and iron overload (8). We therefore undertook a comprehensive study of changes in the pancreatic enzyme concentrations/activity in serum of subjects with primary or secondary SS, and the possible effect of (a) associated autoimmune abnormalities and (b) the duration of disease.
Patients and Methods

Patients
Thirty-five patients with SS were included in this study. Nine had EA, four had systemic lupus erythematosus (SLE), and 22 had primary SS according to standard criteria (9). All patients had symptoms of xerophthalmia and xerostomin. The diagnosis of 55 was based on documentation of keratoconjunctivitis sicca and evidence of salivary gland involvement (9); keratoconjunctivitis sicca was judged present by (a) decreased tear flow rate by Schirmer's test (less than 10 mm wetting ofthe paper strip in5 mm) and (b) abnormal staining of the cornea and conjunctiva with rose bengal dye. Xerostomia was judged present by (a) lack of pool of saliva under the tongue and (b) decreased stimulated salivary flow rate. Exclusions recently proposed by Fox et al.
e.g., pre-existing lymphoma and sarcoidosis, were strictly adhered to.
The findings of a full clinical examination of each patient were recorded, including presence or absence of salivary gland swelling and evidence of any clearly definable connective-tissue disorder. Primary 55 was diagnosed only in the absence of a recognizable connective-tissue disorders such as SLE, scieroderma, or mixed connective tissue disease. None of'the patients included in this study had an impaired renal function: the concentration of urea in plasma was <6.5 mmol/L and creatinine was <120 .imol/L.
Controls
The control group comprised 100 normal subjects (60 men, 40 women), ages 18-60 years. Methods Blood samples were obtained from all these patients; the serum was separated and frozen at -20 #{176}C. Rheumatoid factor and antinuclear factor were assayed in all sera. The concentrations of immunoreactive trypsin (EC 3.4.21.4; ffi'l and the activities of pancreatic and salivary amylase (EC 3.2.1.1) isoenzymes in serum were also measured. IRT was measured with a specific radioimmunoassay kit (Hoechst, Hounslow, U.K.), as previously described (6) . Pancreatic and salivary isoamylases were measured by an enzymatic method based on a kit (Phadebas; Pharmacia, Uppsala, Sweden), as previously described (11).
Statistical comparisons
were by Student's t-tests, linear regression analysis, and tests. 
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Fig. 1. Immunoreactive tiypsin (IRT) concentrations in 35 patients with
Sjogren's syndrome (55) and 100 controls The mean ± 50 indicated for each groupdiffersignificantly (p <0.0001)
Results
Twenty-five of the 35 patients investigated had abovenormal IRT concentrations (see Figure 1) . Of the 22 with primary 55,19 had an increased concentration of IRT. Five of nine patients with RA and SS had increased IRT, but only one of four with SLE did. The mean (±SD) IRT concentration in 55 patients (0.55 ± 0.1 mg/L) was significantly greater than that in controls (0.27 ± 0.07 mgfL, p <0.001).
Pancreatic amylase was increased in seven patients, six of whom had primary 55, the seventh being one of the nine patients with RA. The mean pancreatic amylase (148±68 U/L) in SS patients was not significantly different from that in controls (130±45 U/L). Salivary amylase activity was subnormal in six patients; all except one had primary SS and one had RA. Five of these six patients with low salivary amylase had increased LET; only two had above-normal pancreatic amylase activity. Four of the six patients with subnormal salivary amylase had had SS longer than 10 years.
There was a highly significant correlation between LET concentration and pancreatic isoamnylase activity (r = 0.70, p <0.0001), but no correlation between salivary isoamylase and JET or between salivary and pancreatic isoamylase. The presence of salivary gland swelling and salivary gland antibodies, rheumatoid factor, or antinuclear antibody was not related to increases in LET concentrations.
The mean (± SD) lET in patients who had had SS longer than 10 Eather, the increase of LET in these patients is a marker of subclinical pancreatic damage/abnormality, which we have previously observed in patients with cystic fibrosis (7) or thalassemia major with iron overload (8), in the elderly (13) , and after steroid administration in large doses (14) . The fact that the frequency of above-normal concentrations of LET is greater than that of above-normal pancreatic isoamylase activity is probably due to the fact that the radioimmunoassay of LET measures both trypsinogen and trypsin, whereas the pancreatic isoaxnylase assay measures the enzyme activity only. Damage to the acinar cells probably allows the proenzyme to leak into blood in larger quantities than the activated enzyme. Nevertheless, the highly significant correlation between LET and pancreatic isoamylase in these patients is interesting, as is the observation that early damage of the pancreas may result in hypersecretion of pancreatic juice into the duodenal lumen (15) .
The frequency of above-normal values for LET and pancreatic amylase was greater in patients with primary SS than in those with secondary SS, probably because of the stage in the natural history of the "exocrine pathology" at the time of presentation. Patients with RA and primary biliary cirrhosis may be likely to present at earlier stages of "exocrine pathology."
We were surprised to see the low prevalence of subnormal salivary isoamylase activity in a disease characterized clinically by salivary hyposecretion. We had anticipated a greater frequency of abnormal salivary isoamylase. Apparently a low salivary isoamylase in serum occurs only late in the disorder: four of the six patients with depressed activities of salivary isoamylase had had SS longer than 10 years. Subnormal salivary isoamylase values were associated with increased lET in five patients. Salivary amylase was increased only in one patient, who also had an increase in pancreatic isoamylase and markedly increased LET. We also find it interesting that LET and pancreatic and salivary amylase were not related to any of the clinical features or autoantibodies studied, but there was a correlation between the duration of the disease and pancreatic and salivary abnormalities.
In conclusion: SS is associated with frequent pancreatic abnormality that is independent of the extent of salivary gland abnormality but dependent upon the duration of the disease.
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